| Product Code: ETC6554715 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The oral antiviral import shipments to Bulgaria in 2024 saw a significant increase in concentration, with top exporting countries including Germany, Netherlands, Switzerland, Ireland, and Metropolitan France. The Market Top 5 Importing Countries and Market Competition (HHI) Analysis has experienced steady growth with a CAGR of 9.4% from 2020 to 2024. The low concentration in 2023 further decreased to very low concentration in 2024, indicating a more diversified import Market Top 5 Importing Countries and Market Competition (HHI) Analysis . The growth rate in 2024 alone was 5.48%, highlighting the continued demand for oral antiviral products in Bulgaria.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bulgaria Oral Antiviral Market Overview |
3.1 Bulgaria Country Macro Economic Indicators |
3.2 Bulgaria Oral Antiviral Market Revenues & Volume, 2022 & 2032F |
3.3 Bulgaria Oral Antiviral Market - Industry Life Cycle |
3.4 Bulgaria Oral Antiviral Market - Porter's Five Forces |
3.5 Bulgaria Oral Antiviral Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.6 Bulgaria Oral Antiviral Market Revenues & Volume Share, By Drug class, 2022 & 2032F |
3.7 Bulgaria Oral Antiviral Market Revenues & Volume Share, By Distribution channel, 2022 & 2032F |
4 Bulgaria Oral Antiviral Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of viral infections in Bulgaria |
4.2.2 Growing awareness about the importance of early treatment of viral infections |
4.2.3 Technological advancements leading to the development of more effective oral antiviral drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of oral antiviral drugs |
4.3.2 Competition from alternative treatment options such as injectable antivirals |
4.3.3 High cost associated with oral antiviral medications |
5 Bulgaria Oral Antiviral Market Trends |
6 Bulgaria Oral Antiviral Market, By Types |
6.1 Bulgaria Oral Antiviral Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Bulgaria Oral Antiviral Market Revenues & Volume, By Indication, 2022 - 2032F |
6.1.3 Bulgaria Oral Antiviral Market Revenues & Volume, By Hepatitis, 2022 - 2032F |
6.1.4 Bulgaria Oral Antiviral Market Revenues & Volume, By Human Immunodeficiency Virus (HIV), 2022 - 2032F |
6.1.5 Bulgaria Oral Antiviral Market Revenues & Volume, By Influenza, 2022 - 2032F |
6.1.6 Bulgaria Oral Antiviral Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 Bulgaria Oral Antiviral Market, By Drug class |
6.2.1 Overview and Analysis |
6.2.2 Bulgaria Oral Antiviral Market Revenues & Volume, By Protease inhibitors, 2022 - 2032F |
6.2.3 Bulgaria Oral Antiviral Market Revenues & Volume, By Reverse transcriptase inhibitors, 2022 - 2032F |
6.2.4 Bulgaria Oral Antiviral Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 Bulgaria Oral Antiviral Market, By Distribution channel |
6.3.1 Overview and Analysis |
6.3.2 Bulgaria Oral Antiviral Market Revenues & Volume, By Hospital pharmacies, 2022 - 2032F |
6.3.3 Bulgaria Oral Antiviral Market Revenues & Volume, By Drug store and retail pharmacies, 2022 - 2032F |
6.3.4 Bulgaria Oral Antiviral Market Revenues & Volume, By Online providers, 2022 - 2032F |
7 Bulgaria Oral Antiviral Market Import-Export Trade Statistics |
7.1 Bulgaria Oral Antiviral Market Export to Major Countries |
7.2 Bulgaria Oral Antiviral Market Imports from Major Countries |
8 Bulgaria Oral Antiviral Market Key Performance Indicators |
8.1 Number of prescriptions for oral antiviral drugs |
8.2 Patient adherence rate to oral antiviral treatment |
8.3 Number of reported cases of viral infections in Bulgaria |
9 Bulgaria Oral Antiviral Market - Opportunity Assessment |
9.1 Bulgaria Oral Antiviral Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.2 Bulgaria Oral Antiviral Market Opportunity Assessment, By Drug class, 2022 & 2032F |
9.3 Bulgaria Oral Antiviral Market Opportunity Assessment, By Distribution channel, 2022 & 2032F |
10 Bulgaria Oral Antiviral Market - Competitive Landscape |
10.1 Bulgaria Oral Antiviral Market Revenue Share, By Companies, 2025 |
10.2 Bulgaria Oral Antiviral Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here